Titre : Cocancérogenèse

Cocancérogenèse : Questions médicales fréquentes

Termes MeSH sélectionnés :

Randomized Controlled Trials as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cocancérogenèse : Questions médicales les plus fréquentes", "headline": "Cocancérogenèse : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cocancérogenèse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-05", "dateModified": "2025-03-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cocancérogenèse" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Carcinogenèse", "url": "https://questionsmedicales.fr/mesh/D063646", "about": { "@type": "MedicalCondition", "name": "Carcinogenèse", "code": { "@type": "MedicalCode", "code": "D063646", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.098" } } }, "about": { "@type": "MedicalCondition", "name": "Cocancérogenèse", "alternateName": "Cocarcinogenesis", "code": { "@type": "MedicalCode", "code": "D003043", "codingSystem": "MeSH" } }, "citation": [ { "@type": "ScholarlyArticle", "name": "A randomized controlled trial evaluating the effects of motivational interviewing in new hearing aid users (MI-HAT): study protocol for a randomized controlled trial.", "datePublished": "2023-05-22", "url": "https://questionsmedicales.fr/article/37217960", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-023-07352-7" } }, { "@type": "ScholarlyArticle", "name": "Protocol for a randomized controlled trial: exercise-priming of CBT for depression (the CBT+ trial).", "datePublished": "2024-10-07", "url": "https://questionsmedicales.fr/article/39375728", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-024-08495-x" } }, { "@type": "ScholarlyArticle", "name": "Understanding explanatory and pragmatic trials: Examples from randomized controlled trials on vertebroplasty.", "datePublished": "2022-12-23", "url": "https://questionsmedicales.fr/article/36566693", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.neuchi.2022.101403" } }, { "@type": "ScholarlyArticle", "name": "Emulating Randomized Controlled Trials with Hybrid Control Arms in Oncology: A Case Study.", "datePublished": "2023-01-22", "url": "https://questionsmedicales.fr/article/36606735", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cpt.2841" } }, { "@type": "ScholarlyArticle", "name": "Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35804404", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-022-06365-y" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Processus pathologiques", "item": "https://questionsmedicales.fr/mesh/D010335" }, { "@type": "ListItem", "position": 4, "name": "Processus néoplasiques", "item": "https://questionsmedicales.fr/mesh/D009385" }, { "@type": "ListItem", "position": 5, "name": "Carcinogenèse", "item": "https://questionsmedicales.fr/mesh/D063646" }, { "@type": "ListItem", "position": 6, "name": "Cocancérogenèse", "item": "https://questionsmedicales.fr/mesh/D003043" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cocancérogenèse - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cocancérogenèse", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cocancérogenèse", "description": "Comment diagnostiquer la cocancérogenèse ?\nQuels tests sont utilisés pour évaluer la cocancérogenèse ?\nQuels signes cliniques peuvent indiquer une cocancérogenèse ?\nLa cocancérogenèse est-elle détectable par imagerie ?\nQuel rôle jouent les antécédents médicaux dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cocancérogenèse", "description": "Quels sont les symptômes associés à la cocancérogenèse ?\nLa cocancérogenèse provoque-t-elle des douleurs ?\nY a-t-il des symptômes spécifiques selon le type de cancer ?\nLes symptômes de cocancérogenèse sont-ils toujours visibles ?\nComment les symptômes évoluent-ils avec le temps ?", "url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cocancérogenèse", "description": "Comment prévenir la cocancérogenèse ?\nLe dépistage précoce aide-t-il à prévenir la cocancérogenèse ?\nQuels aliments aident à prévenir la cocancérogenèse ?\nL'exercice physique joue-t-il un rôle dans la prévention ?\nLes vaccinations peuvent-elles prévenir la cocancérogenèse ?", "url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cocancérogenèse", "description": "Quels traitements sont disponibles pour la cocancérogenèse ?\nLa prévention est-elle un traitement pour la cocancérogenèse ?\nLes traitements varient-ils selon le type de cancer ?\nLa thérapie ciblée est-elle efficace contre la cocancérogenèse ?\nQuels sont les effets secondaires des traitements ?", "url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cocancérogenèse", "description": "Quelles complications peuvent survenir avec la cocancérogenèse ?\nLa cocancérogenèse peut-elle entraîner des complications respiratoires ?\nY a-t-il des complications liées aux traitements ?\nComment gérer les complications de la cocancérogenèse ?\nLes complications peuvent-elles affecter la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cocancérogenèse", "description": "Quels sont les principaux facteurs de risque de cocancérogenèse ?\nL'hérédité joue-t-elle un rôle dans la cocancérogenèse ?\nLes infections peuvent-elles être un facteur de risque ?\nLe mode de vie influence-t-il le risque de cocancérogenèse ?\nL'exposition à la radiation est-elle un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la cocancérogenèse ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la cocancérogenèse ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de dépistage, biopsies et analyses génétiques peuvent être utilisés." } }, { "@type": "Question", "name": "Quels signes cliniques peuvent indiquer une cocancérogenèse ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des lésions cutanées ou des anomalies cellulaires peuvent apparaître." } }, { "@type": "Question", "name": "La cocancérogenèse est-elle détectable par imagerie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie peut aider à visualiser des tumeurs, mais pas la cocancérogenèse elle-même." } }, { "@type": "Question", "name": "Quel rôle jouent les antécédents médicaux dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents d'exposition à des agents carcinogènes sont cruciaux pour le diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes associés à la cocancérogenèse ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure fatigue, douleurs inexpliquées et changements de peau." } }, { "@type": "Question", "name": "La cocancérogenèse provoque-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs peuvent survenir en raison de tumeurs ou d'inflammation associée." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques selon le type de cancer ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes varient selon le type de cancer lié à la cocancérogenèse." } }, { "@type": "Question", "name": "Les symptômes de cocancérogenèse sont-ils toujours visibles ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, certains symptômes peuvent être asymptomatiques et nécessitent un dépistage." } }, { "@type": "Question", "name": "Comment les symptômes évoluent-ils avec le temps ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent s'aggraver avec le temps si la cocancérogenèse progresse." } }, { "@type": "Question", "name": "Comment prévenir la cocancérogenèse ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les agents carcinogènes et adopter un mode de vie sain sont essentiels." } }, { "@type": "Question", "name": "Le dépistage précoce aide-t-il à prévenir la cocancérogenèse ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage précoce peut détecter des anomalies avant qu'elles ne deviennent cancéreuses." } }, { "@type": "Question", "name": "Quels aliments aident à prévenir la cocancérogenèse ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en fruits, légumes et antioxydants peut réduire les risques." } }, { "@type": "Question", "name": "L'exercice physique joue-t-il un rôle dans la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut diminuer le risque de développer des cancers." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles prévenir la cocancérogenèse ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations, comme celles contre le HPV, peuvent réduire le risque de cancer." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour la cocancérogenèse ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie." } }, { "@type": "Question", "name": "La prévention est-elle un traitement pour la cocancérogenèse ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, éviter les agents carcinogènes est une forme de traitement préventif." } }, { "@type": "Question", "name": "Les traitements varient-ils selon le type de cancer ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements sont adaptés en fonction du type de cancer et de son stade." } }, { "@type": "Question", "name": "La thérapie ciblée est-elle efficace contre la cocancérogenèse ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie ciblée peut être efficace pour certains cancers liés à la cocancérogenèse." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure nausées, fatigue et immunosuppression." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec la cocancérogenèse ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la progression du cancer et la métastase vers d'autres organes." } }, { "@type": "Question", "name": "La cocancérogenèse peut-elle entraîner des complications respiratoires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains cancers peuvent affecter la fonction pulmonaire et causer des complications." } }, { "@type": "Question", "name": "Y a-t-il des complications liées aux traitements ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent entraîner des complications comme l'infection ou l'anémie." } }, { "@type": "Question", "name": "Comment gérer les complications de la cocancérogenèse ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La gestion implique un suivi médical régulier et des traitements symptomatiques." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent significativement altérer la qualité de vie des patients." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque de cocancérogenèse ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le tabagisme, l'exposition à des produits chimiques et l'alcool." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle dans la cocancérogenèse ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de cancer augmentent le risque de cocancérogenèse." } }, { "@type": "Question", "name": "Les infections peuvent-elles être un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections, comme le HPV, sont des facteurs de risque connus pour le cancer." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque de cocancérogenèse ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque." } }, { "@type": "Question", "name": "L'exposition à la radiation est-elle un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des radiations ionisantes est un facteur de risque pour certains cancers." } } ] } ] }

Sources (10000 au total)

A randomized controlled trial evaluating the effects of motivational interviewing in new hearing aid users (MI-HAT): study protocol for a randomized controlled trial.

Hearing loss is the third leading global cause of disability and is associated with poorer quality of life. Hearing aids are often recommended for hearing loss; however, hearing aid uptake and use rat... A multi-center, prospective, randomized patient-blind controlled trial with a pre- and post-tests design. New hearing aid users ≥ 18 years of age will be recruited from Vancouver, Canada. They will be... This trial is designed to evaluate the efficacy of one-on-one MI in improving hearing aid use in new adult users in the short and long terms. Results will contribute to the evidence on whether MI coun... ClinicalTrials.gov NCT04673565 . Registered on 17 December 2020....

Protocol for a randomized controlled trial: exercise-priming of CBT for depression (the CBT+ trial).

Depression is a leading cause of disability worldwide, and treatments could be more effective. Identifying methods to improve treatment success has the potential to reduce disease burden dramatically.... The CBT + trial will be a parallel-arm randomized controlled trial that will recruit 40 adult participants with DSM-5 diagnosed depression (verified with clinical interview) via referrals, mass emails... The novel approach of priming CBT with moderate-intensity aerobic exercise evaluated in a randomized controlled trial (CBT + trial) has the potential to demonstrate the usefulness of exercise as an au... ClinicalTrials.gov NCT06001346 . Registered on August 21, 2023....

Understanding explanatory and pragmatic trials: Examples from randomized controlled trials on vertebroplasty.

To better understand the explanatory-pragmatic distinction in the design and interpretation of randomized controlled trials (RCTs).... We review the explanatory-pragmatic distinction in clinical trial design. We use the PRECIS-2 tool to evaluate the trial design of selected RCTs on percutaneous vertebroplasty for osteoporotic vertebr... The selection of criteria and the scoring of multiple PRECIS domains were subjective and thus debatable. The pragmascope patterns of various vertebroplasty trials were heterogeneous. Many trials had b... The results of a trial cannot be interpreted without understanding the various design choices made along the explanatory-pragmatic spectrum....

Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial.

Lingual microcystic lymphatic malformations (LMLMs) are rare congenital vascular malformations presenting as clusters of cysts filled with lymph fluid or blood. Even small well-limited lesions can be ... This is a randomized, multicentric study using an individually randomized stepped-wedge design over 24 weeks to evaluate topical application of a 1 mg/mL sirolimus solution once daily, on LMLM, versus... Given the disappointing state of current treatment options in LMLMs, topical sirolimus could become firstline therapy in treating LMLMs if its efficacy and safety were to be demonstrated.... ClinicalTrials.gov NCT04128722 . Registered on 24 September 2019. EudraCT: EUCTR2019-001530-33-FR Sponsor (University Hospital Center of Tours - CHRU Tours): DR190041-TOPGUN French regulatory authorit...

Ayurveda Management of Allergic Rhinitis: Protocol for a Randomized Controlled Trial.

Allergic rhinitis (AR) is the inflammation of the membranes lining the nose due to allergen exposure and is characterized by sneezing, nasal congestion, itching of the nose, or postnasal discharge. Th... The primary aim is to assess the efficacy of Ayurvedic management for AR (or vataja pratishyaya) by comparing it to a conventional control group. The secondary aims are to determine the mean change in... This ongoing study is an open-label randomized controlled interventional trial, with a sample size of 90 both in the trial and standard control group (including dropouts, 20%), and will be carried out... As of May 2024, 72 patients have been enrolled in both groups. Data analysis should be completed by February 2025. The study will be reported following standard guidelines for reporting randomized con... The Ayurvedic approach could be an evidence-based therapeutic tactic for the management of AR.... Clinical Trials Registry India CTRI/2023/06/053395; https://tinyurl.com/564d2zz8.... DERR1-10.2196/56063....

Scandinavian trial of uncomplicated aortic dissection therapy: study protocol for a randomized controlled trial.

Contemporary management of uncomplicated type B aortic dissections (uTBAD) is based on the acuity and various morphological features. Medical therapy is mandatory, while the risks of early thoracic en... The trial is a randomized, open-label, superiority clinical trial with parallel assignment of subjects at 23 clinical sites in Denmark, Norway, Sweden, Finland, and Iceland. Eligibility includes patie... This trial will evaluate the primary question of whether early TEVAR improves survival at 5 years among uTBAD patients. Moreover, the costs and the impact on quality of life should provide sorely need... ClinicalTrials.gov NCT05215587. Registered on January 31, 2022....

Optimizing tobacco treatment delivery for people with HIV: trial protocol for a randomized controlled trial.

With advances in antiretroviral therapy, people with HIV (PWH) are living longer and are less likely to die from AIDS-related complications. Yet, prior research has shown that smoking is often not add... The current study is a type 1 hybrid effectiveness-implementation trial to evaluate the impact of a proactive, opt-out tobacco treatment intervention on cessation outcomes and advance understanding of... This study will examine a novel approach to optimizing tobacco treatment delivery for PWH. Integrating effectiveness and implementation results will help define best practices for engaging PWH with ev... ClinicalTrials.gov: NCT05019495 (August 24, 2021)....

Acupuncture as Adjuvant Therapy for Glaucoma: Protocol for a Randomized Controlled Trial.

Glaucoma is a chronic progressive optic neuropathy that necessitates lifelong treatment to reduce the decline of the optic nerve. Due to the extended and continuous treatments required for patients, c... The primary objective of this study is to conduct a single-center randomized control trial involving patients with glaucoma. Acupuncture will be evaluated as an adjunctive therapy. The trial aims to e... In this single-center randomized controlled trial, participants (N=50) with primary open-angle glaucoma will be randomly assigned to the treatment group, receiving ophthalmic acupuncture with "De Qi" ... Recruitment of participants for the trial commenced on June 28, 2023. A total of 10 participants have been enrolled to test the feasibility of the experiment. We anticipate that the preliminary data f... This trial uses rigorous methodology and comprehensive outcome measurements to assess the clinical efficacy of acupuncture as an adjunctive therapy for glaucoma, providing valuable insights for future... ClinicalTrials.gov NCT05753137; https://clinicaltrials.gov/study/NCT05753137.... DERR1-10.2196/57888....